Effcacy and safety results of a multi-center phase I/II study of utidelone capsule, a novel oral microtubule inhibitor.
Year: 2025
Type: article
Source: Journal of Clinical Oncology
Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Liaoning Cancer Hospital & Institute, Sun Yat-sen University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, First Affiliated Hospital of Xi'an Jiaotong University, Shandong Tumor Hospital, Shandong First Medical University, Wuhan Union Hospital, Huazhong University of Science and Technology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410804449